Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Shaefer

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Transplantation Proceedings|February 1, 1991
Fungal disease in liver transplant recipients: a multivariate analysis of risk factorsP Castaldo, R J Stratta, R P Wood, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 11, 1992
Histologic changes in liver allograft biopsies associated with elevated whole blood and tissue cyclosporine concentrationsJ L Wisecarver, R A Earl, M C Haven, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1989
Clinical patterns of cytomegalovirus disease after liver transplantationR J Stratta, M S Shaefer, R S Markin, et al.
HIV Medicine|January 20, 2006
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicityP N Kumar, A Rodriguez-French, M A Thompson, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1991
Clinical spectrum of fungal infections after orthotopic liver transplantationP Castaldo, R J Stratta, R P Wood, et al.
Transplantation|January 1, 1991
Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipientsR J Stratta, M S Shaefer, K A Cushing, et al.
The American Journal of Gastroenterology|November 1, 1993
Successful application of extracorporeal liver perfusion: a technology whose time has comeI J Fox, A N Langnas, L W Fristoe, et al.
Advances in Therapy|November 8, 2001
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcomeR A DeMasi, N M Graham, J M Tolson, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Transplantation Proceedings|February 1, 1991
Fungal disease in liver transplant recipients: a multivariate analysis of risk factorsP Castaldo, R J Stratta, R P Wood, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 11, 1992
Histologic changes in liver allograft biopsies associated with elevated whole blood and tissue cyclosporine concentrationsJ L Wisecarver, R A Earl, M C Haven, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1989
Clinical patterns of cytomegalovirus disease after liver transplantationR J Stratta, M S Shaefer, R S Markin, et al.
HIV Medicine|January 20, 2006
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicityP N Kumar, A Rodriguez-French, M A Thompson, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1991
Clinical spectrum of fungal infections after orthotopic liver transplantationP Castaldo, R J Stratta, R P Wood, et al.
Transplantation|January 1, 1991
Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipientsR J Stratta, M S Shaefer, K A Cushing, et al.
The American Journal of Gastroenterology|November 1, 1993
Successful application of extracorporeal liver perfusion: a technology whose time has comeI J Fox, A N Langnas, L W Fristoe, et al.
Advances in Therapy|November 8, 2001
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcomeR A DeMasi, N M Graham, J M Tolson, et al.
Pageof 3